INS and Obesity: Since butyrate and other SCFAs have been reported to increase insulin sensitivity and glucagon-like-peptide-1 (GLP1) release in animal studies, reduced SCFA levels in pregnant women, and especially pregnant women with obesity, may be contributing factors for the insulin resistance commonly observed during pregnancy (37, 38).